Skip to main content

2 Result(s)

within P Rujkijyanont Remove this filter

and

  1. No Access

    Article

    Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors

    Thalassemia-free survival after allogeneic stem cell transplantation (SCT) is about 80–90% with either matched-related or -unrelated donors. We explored the use of a mismatched-related (‘haplo- ’) donor. All p...

    U Anurathapan, S Hongeng, S Pakakasama, N Sirachainan… in Bone Marrow Transplantation (2016)

  2. Article

    Open Access

    Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia

    Donor lymphocyte infusion (DLI) is commonly used to treat leukemia relapse following stem cell transplantation. In florid relapse, however, the efficacy of DLI is limited with substantial risk of severe graft-...

    P Rujkijyanont, C Morris, G Kang, K Gan, C Hartford, B Triplett… in Blood Cancer Journal (2013)

    Download PDF (424 KB) View Article